Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiative

Low-quality medicines deliver sub-optimal clinical outcomes and waste precious health resources. It is important to ensure that public funds are spent on healthcare technologies that meet national regulatory bodies such as the Saudi Food and Drug Authority (SFDA), quality standards for safety, effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhawassi, Tariq M., Abuelizz, Hatem A., Almetwazi, Mansour, Mahmoud, Mansour A., Alghamdi, Ahmed, Alruthia, Yazed S., BinDhim, Nasser, Alburikan, Khalid A., Asiri, Yousif A., Pitts, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783811/
https://www.ncbi.nlm.nih.gov/pubmed/29379335
http://dx.doi.org/10.1016/j.jsps.2017.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783811/
https://www.ncbi.nlm.nih.gov/pubmed/29379335
http://dx.doi.org/10.1016/j.jsps.2017.10.011

Ejemplares similares